Rocket Pharmaceuticals Inc (RCKT) Stock Analysis

Rocket Pharmaceuticals Inc (RCKT) is a publicly traded company in the HEALTHCARE sector. It trades at $3.91, carries a market capitalization of $457.52M. This page summarizes the public market data, fundamentals, and frequently asked questions for RCKT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Price: $3.91
Market Cap: $457.52M
EPS: $-1.87
52-Week High: $5.45
52-Week Low: $2.53

Market Sentiment

Rocket Pharmaceuticals Inc currently has a Neutral sentiment score of -0.02.

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc. is a pioneering biotechnology firm headquartered in Cranbury, New Jersey, specialized in developing innovative gene therapies for rare and life-threatening pediatric disorders. With its proprietary platform technologies, Rocket is committed to addressing substantial unmet medical needs through transformative therapeutic solutions. The company's extensive pipeline reflects its dedication to enhancing patient outcomes and revolutionizing the treatment landscape for ...

GNG Research Analysis

GNG Research scores Rocket Pharmaceuticals Inc (RCKT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RCKT.

Frequently Asked Questions

Does RCKT pay dividends?

Rocket Pharmaceuticals Inc (RCKT) does not currently pay a regular dividend.

What is RCKT's market cap?

Rocket Pharmaceuticals Inc (RCKT) has a market capitalization of $457.52M with a current stock price of $3.91.